SMTL ID : 8wd4.1

EGFR(L858R/T790/C797S) in complex with compound 5j

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

monomer

Ligands

1 x W7W: ~{N}-[3,3-bis(fluoranyl)propyl]-4-[[(2~{S})-butan-2-yl]amino]-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]pyridine-3-carboxamide(Non-covalent)

W7W.1: 17 residues within 4Å: Chain A: L.25, F.30, V.33, A.50, K.52, C.82, M.97, Q.98, L.99, M.100, P.101, G.103, R.148, N.149, L.151, T.161, D.162 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.25, A:L.25, A:M.97, A:L.151, A:T.161 Hydrogen bonds: A:Q.98, A:M.100, A:M.100

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 1 residues within 4Å: Chain A: R.138 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kageji, H. et al., Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation. Bioorg.Med.Chem.Lett. (2023)

Release Date

2023-12-20

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor